Research graph

References

References from Targeting SLC38A5 Overcomes αPD-1 Immunotherapy Resistance by Alleviating Glutamine Competition Between Glioblastoma Cells and T Cells. Local targets link to admitted publications; unresolved targets remain external evidence.

No reference evidence is available for this admitted work.